EGFR and lung carcinoma: Clinical analysis revealed a significantly higher miR-146b-5p expression in pleural effusions-isolated lung cancer cells from treatment-naive patients than acquiring resistance patients to EGFR-TKI treatment [172,229,230,231,232].